| Financial Year |
March 31 2023 |
| Monetary Funds |
19,873,380,660.70 |
| Held-for-trading Financial Assets |
139,207,879.12 |
| Notes Receivable |
112,919,281.02 |
| Accounts Receivable |
10,515,345,982.29 |
| Advances to Suppliers |
7,298,541,376.59 |
| Other Receivables |
10,973,480.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,932,269.40 |
| Inventories |
30,034,841,393.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,519,383.74 |
| Other Current Assets |
1,344,087,986.32 |
| Total Current Assets |
70,894,333,157.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,731,478.00 |
| Long-term Equity Investment |
1,686,536,548.83 |
| Investment Properties |
79,934,579.65 |
| Fixed Assetes |
8,106,341,057.19 |
| Under-construction Projects |
668,789,865.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,791,784,673.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,901,904.79 |
| Deferred Income Tax Assets |
144,429,340.47 |
| Other Non-Current Assets |
797,874,944.49 |
| Sub-Total of Non-Current Assets |
14,710,417,796.17 |
| Total Assets |
85,604,750,953.98 |
| Short-Term Loans |
2,118,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,578,494,951.19 |
| Accounts Payable |
33,342,455,294.31 |
| Accounts Received In Advance |
621,772.05 |
| Employee Compensation Payable |
421,263,761.02 |
| Taxes Payable |
117,960,824.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
575,903,986.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
159,098,406.83 |
| Other Current Liabilities |
2,717,612,344.76 |
| Sub-Total of Current Liabilities |
67,269,570,250.54 |
| Long-term Loans |
254,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
97,689,084.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
547,378,210.33 |
| Deferred Income Tax Liabilities |
126,042,799.97 |
| Other Non-Current Liabilities |
3,181,535.70 |
| Sub-Total of Non-Current Liabilities |
1,937,535,692.85 |
| Total Liabilities |
69,207,105,943.39 |
| Paid-In Capital(Or Share Stock) |
2,781,740,071.00 |
| Capital Surplus |
8,505,719,907.00 |
| Surplus Reserve |
1,299,186,225.33 |
| LESS:Treasury Stock |
176,127,750.00 |
| Undistributed Profits |
3,271,573,836.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,397,645,010.59 |
| Owner's Equity（Stockholder's Equity） |
16,397,645,010.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
85,604,750,953.98 |
